⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31522600 | 1.00 | — | — | |
| SCHEMBL18071801 | 1.00 | — | — | |
| SCHEMBL8210960 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL3319114 | 0.97 | — | — | |
| SCHEMBL9267031 | 0.86 | CHRNA7 (0.48) | — | |
| SCHEMBL66150 | 0.86 | — | — | |
| SCHEMBL66151 | 0.86 | — | — | |
| SCHEMBL1039747 | 0.86 | — | — | |
| SCHEMBL21087936 | 0.86 | — | — | |
| SCHEMBL71473 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0307140-A1 | Oxadiazolyl-azabicycloheptanes for the treatment of senile dementia | MERCK SHARP & DOHME LTD. (GB) | 1989-03-15 | — | — | EP | claimed |
| EP-4559918-A2 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | Genzyme Corporation (US) | 2025-05-28 | — | — | EP | disclosed |
| EP-3673906-B1 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | GENZYME CORP (US) | 2025-05-14 | — | — | EP | disclosed |
| WO-2025077825-A1 | METHODS AND COMPOSITIONS FOR TREATING CARDIO-PULMONARY DISORDERS | FAUNA BIO INCORPORATED (US) | 2025-04-17 | — | — | WO | disclosed |
| CN-113950477-B | Granulin precursor modulators and methods of use thereof | 阿库达医疗公司 | 2024-07-05 | — | — | CN | disclosed |
| US-20240124474-A1 | HER2 MUTATION INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2024-04-18 | — | — | US | disclosed |
| US-20220409595-A1 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | GENZYME CORPORATION | 2022-12-29 | — | — | US | disclosed |
| US-20220251084-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | JANSSEN PHARMACEUTICA NV (BE) | 2022-08-11 | — | — | US | disclosed |
| EP-3983401-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | Arkuda Therapeutics (US) | 2022-04-20 | — | — | EP | disclosed |
| EP-3079695-B1 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | GENZYME CORP (US) | 2021-03-17 | — | — | EP | disclosed |
| EP-0709381-A1 | Heterocyclic compounds and their preparation and use | ELI LILLY AND COMPANY (US) | 1996-05-01 | — | — | EP | disclosed |
| WO-1996008968-A1 | INSECT CONTROL WITH SUBSTITUTED TRIAZOLE AND TETRAZOLE COMPOUNDS | DOWELANCO (US) | 1996-03-28 | — | — | WO | disclosed |
| EP-0427390-B1 | Azabicyclic compounds, process and intermediates for their preparation and pharmaceutical compositions containing them | BEECHAM GROUP PLC (GB) | 1996-03-27 | — | — | EP | disclosed |
| US-5468875-A | Muscarinic agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1995-11-21 | — | — | US | disclosed |
| US-5393767-A | Insect control with substituted triazole and tetrazole compounds | DOWELANCO (US) | 1995-02-28 | — | — | US | disclosed |
| EP-0458214-A1 | Bicyclic 1-azacycloalcanes | BOEHRINGER INGELHEIM KG (DE) | 1991-11-27 | — | — | EP | disclosed |
| EP-0427390-A2 | Azabicyclic compounds, process and intermediates for their preparation and pharmaceutical compositions containing them | BEECHAM GROUP PLC (GB) | 1991-05-15 | — | — | EP | disclosed |
| US-5001133-A | Benzoic acid derivatives | SANDOZ LTD. (CH) | 1991-03-19 | — | — | US | disclosed |
| EP-0257741-A2 | Azabicyclic compounds, process and intermediates for their preparation and pharmaceutical compositions containing them | BEECHAM GROUP PLC (GB) | 1988-03-02 | — | — | EP | disclosed |
| WO-1985002847-A1 | CARBOCYCLIC AND HETEROCYCLIC CARBON ACID ESTERS AND AMIDES OF NITROGENOUS OR NON NITROGENOUS BRIDGED OR UNBRIDGED AMINES OR ALCOHOLS | SANDOZ AG (CH) | 1985-07-04 | — | — | WO | disclosed |